Full-Time
Manufacturing Science & Technology: Senior Analytical Transfer Specialist
Posted on 4/4/2023
Automated cell therapy manufacturing and development platform
Senior
San Bruno, CA, USA
- Bachelor's degree in science, engineering, or related field required
- Knowledge of QC principles, concepts, industry practices, and standards
- Knowledge of and experience in relevant cell therapy characterization analytical methods including flow cytometry, ELISA, cell based assays, qPCR and ddPCR
- Exposure to one or more advanced potency methods, such as cytotoxicity or cytokine characterization
- Understanding of analytical transfer, qualification, and validation, and statistical methods
- Experience writing, reviewing and approving GMP documentation
- Understanding of cGMP and regulations/guidance, can interpret guidance documents and make technical recommendations. (QbD, ICH Validation of analytical procedures, FDA regulations)
- Excellent oral and written communication skills to effectively communicate with internal/external stakeholders, and to author technical documents (protocols, reports, SOP's, investigations, deviations, CAPAs, regulatory filings)
- Creative, self-motivated, flexible to work in a small company environment and assume a wide variety of tasks
- Desire to be part of a rapidly evolving organization, with a compelling technology, and taking products and processes to the next level
- Self-motivated and passionate about advancing the field of cell therapy
- Excellent planning, organization, technical writing, and time-management skills including the ability to support, problem-solve, and prioritize multiple projects and deadlines
- Self-awareness, integrity, authenticity, and a growth mindset
- Lead the transfer of cell therapy analytical methods to QC from internal Cellares AD or directly from customers
- Evaluate analytical methods for feasibility, method improvement, remediation, and/or troubleshooting
- Support analytical method transfer and trending with statistical analysis
- Responsible for the authoring, review, approval, and oversight of analytical method procedures, method development reports, method validation, training/transfer protocols and reports for internal and external analytical methods
- Contribute to authoring of regulatory submissions
- Leads continuous cGMP analytical improvement projects. This includes, but may not be limited to, constant state of validation, improvement of methods and sustaining compliance with global requirements
- Work as the MSAT Analytical Transfer representative on client projects
- Prepare and present data associated with QC processes to internal and external clients
- Define and provide user requirements for QC equipment for the testing of manufactured cell therapies
- Work with our software team on integration solutions for the QC process and data management, including MES, QMS, and LIMS
- Provide technical leadership to QC and other departments associated with GMP QC operations
- Accountable to comply with GxP regulations, guidelines, procedures, and practices governing analytical methods for release and stability testing. Collaborate with internal and external groups cross-functionally as a subject matter expert to ensure compliance, OOS/OOE/OOT investigations, deviations, change controls and CAPAs
- Provide input when troubleshooting processes on the QC floor
- Additional duties as assigned
- 4+ years experience in biologics/gene therapy with a primary focus on analytical method testing and/or transfer for cell therapy products. CDMO experience is a plus
Cellares, as the pioneering Integrated Development and Manufacturing Organization (IDMO), is reshaping the cell therapy manufacturing industry with its unique Industry 4.0 approach, integrating all necessary technologies into a single, high-throughput platform called the Cell Shuttle. This end-to-end automation system not only accelerates drug development and manufacturing but also significantly reduces process failure rates and manufacturing costs. With its strategically located Smart Factories and a robust financial backing of over $355 million, Cellares is well-positioned to meet global patient demand for cell therapies, offering potential partners a competitive edge in the rapidly evolving cell therapy market.
Company Stage
Series C
Total Funding
$373M
Headquarters
South San Francisco, California
Founded
2019